Skip to main content
Equibles
MET logo

MET · Metlife Inc

Track MET — free

Use MET with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about MET

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$97.67 +0.20 (+0.20%)
Market Cap
$61.43B
Shares
635.48M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$97.47 Open$97.02 Day$96.64–97.71 52W close$67.70–99.95 Avg vol 30d3.7M Short int11.3M · 1.8% float · 2.6d Short vol53% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Research

      our published analysis of this company

      Equibles Rating

      blended score · not investment advice
      Overall
      Strong Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very Low
      Market backdrop VIX 14.6 · calm Equity put/call 0.59
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +21%
      above
      Price vs 50-day avg +7%
      above
      RSI (14) 62
      neutral
      MACD trend Negative
      52-week position 92%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +4%
      trailing
      6-month return +23%
      trailing
      YTD return +23%
      this year
      Relative strength +10%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $91 › 200d $81 — 50d above 200d
      Institutional flow Accumulating
      1,289 of 1,388 funds reported for Jun 30 · net +9.6M sh shares · +138 new
      Insider flow Distributing
      Net -$1.7M over 90 days · 100% sells
      Short interest Falling
      1.78% of float · ▼ -11.6% MoM · 2.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      1,388 holders — mid 3-yr range
      Squeeze score 42
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +9%
      Y/Y
      EPS growth −21%
      Y/Y
      Valuation P/E 18.5
      in line
      Buyback $3.0B
      authorized
      Balance sheet $7.2B
      net cash
      Quant / Vol
      risk profile
      Very Low
      Volatility 24%
      annualized · 1-yr
      Max drawdown −18%
      past year
      ATR 1.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Feb 4, 2026
      2026
      Holding company cash target $3B – $4B
      Direct expense ratio, excluding total notable items related to d Non-GAAP 12.1%
      MIM revenues growth 30%
      five-year period of 2025 to 2029
      Free cash flow (cumulative, five-year period 2025 to 2029) $25B
      two-year average annual
      Two-year average annual ratio of free cash flow to adjusted earn 65% – 75%
      2029
      Direct expense ratio, excluding total notable items related to d Non-GAAP 11.3%
      full year 2026
      Total estimated variable investment income (pre-tax) $1.6B
      fiscal year ending March 2026
      Estimated Economic Solvency Ratio 170% – 190%
      2027 and 2028
      MIM adjusted earnings growth Non-GAAP 15% – 20%
      Prior guidance period ended · from the Earnings Call filed Mar 31, 2024
      Variable investment income · full-year 2024 $1.5B
      EMEA adjusted earnings run rate · the remainder of the year $60M – $65M
      Direct expense ratio · full-year 2024 up to 12.3%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +21% Bullish
      Price vs 50-day avg
      +7% Bullish
      RSI (14)
      62 Neutral
      MACD trend
      Negative Bearish
      52-week position
      92% Bullish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $91 › 200d $81 — 50d above 200d
      Institutional flow Accumulating
      1,289 of 1,388 funds reported for Jun 30 · net +9.6M sh shares · +138 new
      Insider flow Distributing
      Net -$1.7M over 90 days · 100% sells
      Short interest Falling
      1.78% of float · ▼ -11.6% MoM · 2.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      1,388 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $68 Now $97 · 92% Range high $100
      vs 200-day avg +21% vs 50-day avg +7%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT non-GAAP 20.8% Three Months Ended June 30, 2026 —
      Asia general account assets under management (at amortized cost) $141.21B Three Months Ended June 30, 2026 —
      Direct expense ratio, excluding total notable items related to direct expenses and PRT non-GAAP 12.1% Three Months Ended June 30, 2026 —
      Holding company cash and liquid assets $3.4B Three Months Ended June 30, 2026 —
      Adjusted earnings per share, excluding total notable items non-GAAP $2.58 Three Months Ended December 31, 2025 —
      Adjusted premiums, fees and other revenues, excluding pension risk transfers (PRT) non-GAAP $49.8B Year Ended December 31, 2025 —
      Adjusted ROE, excluding total notable items non-GAAP 16% Year Ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Insurance - Life — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      MET
      Metlife Inc
      this stock
      		$61.43B +23.5% +8.6% 18.5 1.8%
      CILJF
      China Life Insurance Co Ltd
      		 $100.90B +3.3% — — 0.0%
      MFC
      Manulife Financial Corp
      		 $72.76B +21.1% — — 0.8%
      AFL
      Aflac Inc
      		 $61.01B +9.8% -9.3% 13.1 2.5%
      GWLIF
      Great-West Lifeco Inc.
      		 $58.47B +32.0% — — 0.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      1,458
      % held
      78.7%
      Reported
      1,289 of 1,388
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      1,176
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      11.3M
      Days to cover
      2.6d
      Change
      -1.5M sh
      View
      Short Volume
      Short vol %
      53%
      As of
      Aug 13, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      34
      Value
      $3.1K
      As of
      Jul 6, 2026
      View
      Off-Exchange
      Off-exchange %
      42.2%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$1.7M
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Alan Armstrong
      Amount
      $1.0K–$15.0K
      Traded
      Mar 27, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $77.1B
      Net income (FY)
      $3.4B
      EPS diluted
      $4.71
      View
      Buybacks
      Authorized
      $3.0B
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 6, 2026
      This year
      16
      View
      Proposed Sales
      Value
      $1.7M
      Shares
      21.3K
      Filed
      Jun 1, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View
      Investor Relations
      Latest news
      MetLife to Announce Second Quarte…
      Published
      Jul 9, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      MET -2.5% +4.0% +23.2% +1.4% +23.5%
      SPY +1.2% +3.6% +12.8% +4.1% +14.1%
      vs SPY -3.7% +0.4% +10.4% -2.7% +9.4%

      Capital returns

      Latest dividend
      $0.593 / share · ex Aug 4, 2026
      Raised 4.4%
      Paid (TTM)
      $2.322 / share · 4 payouts
      Dividend yield (TTM, derived)
      2.38%
      Buyback program · as of Aug 5, 2026
      Authorized
      $3.00B
      Spent (derived)
      —
      Remaining
      —

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1099219 CUSIP 59156R108 13F (30d) 1139 filings 1087 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)